These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


116 related items for PubMed ID: 2176946

  • 41. In vivo osmoregulation of aldose reductase mRNA, protein, and sorbitol in renal medulla.
    Cowley BD, Ferraris JD, Carper D, Burg MB.
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F154-61. PubMed ID: 2105661
    [Abstract] [Full Text] [Related]

  • 42. Novel spirosuccinimide aldose reductase inhibitors derived from isoquinoline-1,3-diones: 2-[(4-bromo-2-fluorophenyl)methyl]-6- fluorospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrone and congeners. 1.
    Malamas MS, Hohman TC, Millen J.
    J Med Chem; 1994 Jun 24; 37(13):2043-58. PubMed ID: 8027986
    [Abstract] [Full Text] [Related]

  • 43. Aldose reductase the major protein associated with naphthalene dihydrodiol dehydrogenase activity in rat lens.
    Sato S.
    Invest Ophthalmol Vis Sci; 1993 Oct 24; 34(11):3172-8. PubMed ID: 8407226
    [Abstract] [Full Text] [Related]

  • 44. Rat lens aldose reductase: characterization of its primary structure, mRNA, and gene complexity.
    Nishimura C, Wistow G, Carper D.
    Prog Clin Biol Res; 1989 Oct 24; 290():211-20. PubMed ID: 2498898
    [No Abstract] [Full Text] [Related]

  • 45. Aldose reductase, NADPH and NADP+ in normal, galactose-fed and diabetic rat lens.
    Lee SM, Schade SZ, Doughty CC.
    Biochim Biophys Acta; 1985 Sep 06; 841(3):247-53. PubMed ID: 3927985
    [Abstract] [Full Text] [Related]

  • 46. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats.
    Peterson MJ, Sarges R, Aldinger CE, MacDonald DP.
    Metabolism; 1979 Apr 06; 28(4 Suppl 1):456-61. PubMed ID: 122297
    [Abstract] [Full Text] [Related]

  • 47. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
    Beyer-Mears A, Diecke FP, Mistry K, Cruz E.
    Pharmacology; 1997 Feb 06; 54(2):76-83. PubMed ID: 9088040
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Comparative studies on aldose reductase from bovine, rat and human lens.
    Conrad SM, Doughty CC.
    Biochim Biophys Acta; 1982 Nov 19; 708(3):348-57. PubMed ID: 6816289
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Syntheses of tolrestat analogues containing additional substituents in the ring and their evaluation as aldose reductase inhibitors. Identification of potent, orally active 2-fluoro derivatives.
    Wrobel J, Millen J, Sredy J, Dietrich A, Gorham BJ, Malamas M, Kelly JM, Bauman JG, Harrison MC, Jones LR.
    J Med Chem; 1991 Aug 19; 34(8):2504-20. PubMed ID: 1908522
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175.
    Sato S, Mori K, Wyman M, Kador PF.
    Exp Eye Res; 1998 Feb 19; 66(2):217-22. PubMed ID: 9533847
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.